During a period of rapid fluctuation in the intravenous iron market, there was increased use of a more expensive drug that afforded providers additional revenue. Objectives: Medicare Part B payment ...
A single dose of intravenous (IV) iron dextran is the most cost-effective treatment for women with heavy menstrual bleeding and iron deficiency anemia (IDA), according to new research published in ...
Intravenous iron shows safe and beneficial outcomes for patients with bacterial infection and anemia
Treatment with intravenous (IV) iron significantly improved survival and increased hemoglobin levels in patients with iron-deficiency anemia who were hospitalized for an acute bacterial infection, ...
Change in clinical practice would have clear benefits for patients undergoing major bowel surgery, according to analysis conducted by researchers from UCL and the Royal Devon and Exeter Hospital.
NEW ORLEANS, LA—Two new studies testing iron supplementation in patients with heart failure (HF) have yielded opposite findings, although experts say the differences are likely explained by how the ...
Please provide your email address to receive an email when new articles are posted on . IV iron is the most cost-effective option for women with iron deficiency anemia and heavy menstrual bleeding.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results